Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Israel · Delayed Price · Currency is ILS · Price in ILA

1,092.00

0.00 (0.00%)

Jul 30, 2026, 5:24 PM IDT

TLV:REKA Financials Overview

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	304.15	300.99	321.71	321.66	292.39	263.95
Revenue Growth	-1.31%	-6.44%	0.01%	10.01%	10.78%	-0.57%
Gross Profit	67.29	69.57	71.95	80.2	78.71	65.16
Operating Income	-8.19	-7.25	-7.34	2.91	13.25	12.91
Net Income	-18.54	-18.07	6.21	-6.91	-2.04	6.62
Earnings Per Share	-1.62	-1.58	0.54	-0.61	-0.18	0.58
EPS Growth	-	-	-	-	-	-38.65%

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Extraordinary/Special	16.45	17.02	17.13	15.61	15.69	14.86
Core Products	209.14	208.17	227.33	224.46	189.51	160.74
Distribution	78.56	75.8	77.25	81.59	87.19	88.36
Total	304.15	300.99	321.71	321.66	292.39	263.95

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	6.74	4.38	7.07	19.35	20.29	18.64
Total Debt	131.73	132.39	134.16	183.66	165.7	165.82
Net Cash (Debt)	-124.99	-128.01	-127.09	-164.31	-145.41	-147.18
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-10.94	-11.21	-11.13	-14.39	-12.74	-12.89

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	9.83	12.95	26.54	28.35	39	21.17
Capital Expenditures	-6.47	-7.03	-8.69	-11.49	-6.93	-13.49
Free Cash Flow	3.36	5.92	17.85	16.86	32.07	7.68
Free Cash Flow Growth	-83.90%	-66.82%	5.86%	-47.42%	317.44%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	22.12%	23.11%	22.36%	24.93%	26.92%	24.69%
Operating Margin	-2.69%	-2.41%	-2.28%	0.90%	4.53%	4.89%
Pretax Margin	-4.02%	-3.72%	2.46%	-2.19%	0.12%	2.92%
Profit Margin	-6.09%	-6.00%	1.93%	-2.15%	-0.70%	2.51%
FCF Margin	1.10%	1.97%	5.55%	5.24%	10.97%	2.91%

Dividends

Fiscal Year	FY 2021
Period Ending	Dec '21 Dec 31, 2021
Dividend Per Share	0.868
Dividend Per Share Growth	-
Dividend Yield	3.87%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	24.37	-	-	40.12
P/FCF Ratio	37.64	21.08	8.47	10.01	5.48	34.59
PS Ratio	0.42	0.42	0.47	0.52	0.60	1.01